Capital Analysts LLC’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $250K | Buy |
642
+60
| +10% | +$25.4K | 0.01% | 646 |
|
|
2026
Q1 | $276K | Sell |
582
-30
| -5% | -$15.1K | 0.01% | 577 |
|
|
2025
Q4 | $286K | Sell |
612
-58
| -9% | -$26.9K | 0.01% | 540 |
|
|
2025
Q3 | $286K | Sell |
670
-41
| -6% | -$15.9K | 0.01% | 529 |
|
|
2025
Q2 | $272K | Sell |
711
-125
| -15% | -$45K | 0.01% | 486 |
|
|
2025
Q1 | $289K | Sell |
836
-111
| -12% | -$35.7K | 0.01% | 458 |
|
|
2024
Q4 | $284K | Sell |
947
-5
| -0.5% | -$1.75K | 0.01% | 417 |
|
|
2024
Q3 | $387K | Buy |
952
+82
| +9% | +$30K | 0.02% | 364 |
|
|
2024
Q2 | $280K | Buy |
870
+25
| +3% | +$8.12K | 0.01% | 406 |
|
|
2024
Q1 | $282K | Hold |
845
| – | – | 0.01% | 387 |
|
|
2023
Q4 | $229K | Buy |
845
+56
| +7% | +$13.8K | 0.01% | 400 |
|
|
2023
Q3 | $194K | Buy |
789
+260
| +49% | +$71.1K | 0.01% | 396 |
|
|
2023
Q2 | $161K | Buy |
529
+139
| +36% | +$38.6K | 0.01% | 398 |
|
|
2023
Q1 | $103K | Hold |
390
| – | – | 0.01% | 465 |
|
|
2022
Q4 | $94K | Hold |
390
| – | – | 0.01% | 514 |
|
|
2022
Q3 | $72K | Hold |
390
| – | – | 0.01% | 498 |
|
|
2022
Q2 | $66K | Sell |
390
-2
| -0.5% | -$430 | ﹤0.01% | 506 |
|
|
2022
Q1 | $98K | Sell |
392
-124
| -24% | -$31.1K | 0.01% | 434 |
|
|
2021
Q4 | $133K | Sell |
516
-170
| -25% | -$41.6K | 0.01% | 402 |
|
|
2021
Q3 | $167K | Sell |
686
-13
| -2% | -$3.18K | 0.01% | 366 |
|
|
2021
Q2 | $145K | Hold |
699
| – | – | 0.01% | 382 |
|
|
2021
Q1 | $132K | Hold |
699
| – | – | 0.01% | 406 |
|
|
2020
Q4 | $115K | Hold |
699
| – | – | 0.01% | 295 |
|
|
2020
Q3 | $87K | Buy |
699
+27
| +4% | +$3.34K | 0.01% | 334 |
|
|
2020
Q2 | $65K | Buy |
+672
| New | +$69.9K | 0.01% | 344 |
|
|
2017
Q3 | – | Sell |
-722
| Closed | -$63K | – | 455 |
|
|
2017
Q2 | $63K | Hold |
722
| – | – | 0.01% | 285 |
|
|
2017
Q1 | $64.3K | Hold |
722
| – | – | 0.01% | 246 |
|
|
2016
Q4 | $53K | Hold |
722
| – | – | 0.01% | 271 |
|
|
2016
Q3 | $54.6K | Hold |
722
| – | – | 0.01% | 259 |
|
|
2016
Q2 | $55.6K | Buy |
722
+258
| +56% | +$20.4K | 0.01% | 253 |
|
|
2016
Q1 | $36.2K | Buy |
464
+180
| +63% | +$12.6K | 0.01% | 296 |
|
|
2015
Q4 | $19.2K | Sell |
284
-7,051
| -96% | -$492K | ﹤0.01% | 339 |
|
|
2015
Q3 | $567K | Sell |
7,335
-160
| -2% | -$14.2K | 0.11% | 135 |
|
|
2015
Q2 | $680K | Buy |
7,495
+418
| +6% | +$33.5K | 0.14% | 121 |
|
|
2015
Q1 | $532K | Buy |
7,077
+1,609
| +29% | +$116K | 0.11% | 123 |
|
|
2014
Q4 | $401K | Buy |
+5,468
| New | +$384K | 0.09% | 130 |
|
Other funds holding HCA
Capital Analysts LLC's HCA Position: Q2 2026 in Review
Capital Analysts LLC increased its HCA Healthcare (HCA) stake by 10% in Q2 2026, buying an estimated $25.4K and bringing the position to 642 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #646.
Capital Analysts LLC first reported a position in HCA in Q4 2014 and has held it in 36 quarters since. The position peaked at $680K in Q2 2015. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Capital Analysts LLC held 642 shares of HCA Healthcare worth $250K as of Q2 2026.
- Capital Analysts LLC bought 60 HCA Healthcare shares in Q2 2026, an estimated $25.4K.
- HCA Healthcare made up 0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #646 holding.
- Capital Analysts LLC first reported a position in HCA Healthcare in Q4 2014 and has held it in 36 quarters since.
- Capital Analysts LLC's HCA Healthcare position peaked at $680K in Q2 2015.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.